{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:57:38Z","timestamp":1789984658997,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T00:00:00Z","timestamp":1338940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Psoriasis is an inflammatory disease of the skin and joints. Previous studies have shown a higher prevalence of metabolic syndrome (MS) in psoriatic patients. Recent studies show that non\u2010alcoholic fatty liver disease (NAFLD) is also frequent in psoriasis patients.<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> To investigate the occurrence and severity of NAFLD in South Indian psoriatic patients and healthy controls.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> In phase 1 we performed a case control study on 333 adult psoriasis patients and 330 controls matched by age, sex and body mass index. NAFLD was diagnosed by ultrasonography and liver enzymes after excluding other liver diseases. In phase 2 we compared the NAFLD subgroups in psoriasis patients and controls by determining their fibrosis, steatosis and non\u2010alcoholic steatohepatitis (NASH) scores.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The occurrence of NAFLD was higher in psoriasis patients than in controls (17.4 <jats:italic>vs<\/jats:italic> 7.9%; <jats:italic>P<\/jats:italic>\u2003=\u20030.002). NAFLD patients in the psoriasis group (<jats:italic>n<\/jats:italic>\u2003=\u200358) were more likely to have MS (<jats:italic>P<\/jats:italic>\u2003=\u20030.03) and diabetes (<jats:italic>P<\/jats:italic>\u2003=\u20030.02) than those with psoriasis alone (<jats:italic>n<\/jats:italic>\u2003=\u2003254). The former group had a longer duration of psoriasis and arthritis (<jats:italic>P<\/jats:italic>\u2003=\u20030.003 and 0.005). Psoriasis patients with NAFLD had more severe disease as per the psoriasis area and severity index scores (<jats:italic>P<\/jats:italic>\u2003=\u20030.02). Psoriasis patients had more severe NAFLD than controls as reflected by the steatosis, NASH and fibrosis scores (<jats:italic>P<\/jats:italic>\u2003=\u20030.001, 0.003, 0.03 respectively).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> NAFLD is the commonest liver disease in Indian psoriatic patients when compared to controls. As NAFLD is more severe in psoriasis patients we suggest routine screening for NAFLD in this group especially when systemic therapy is considered.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2012.00905.x","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T12:10:46Z","timestamp":1338984646000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["The increased prevalence of non\u2010alcoholic fatty liver disease in psoriatic patients: A study from South India"],"prefix":"10.1111","volume":"53","author":[{"given":"Shraddha","family":"Madanagobalane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankarasubramanian","family":"Anandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422147"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01773.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1079"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.017"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91336-X"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"e_1_2_6_8_2","first-page":"S100","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farell GC","year":"2006","journal-title":"Hepatology"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80144-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.06.008"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.020"},{"key":"e_1_2_6_12_2","unstructured":"MisraA GhoshA JhinganAKet\u2003al. The outcome of the consensus meeting held at New Delhi on 15\u201316 November 2008 under the Indian Health Ministry."},{"key":"e_1_2_6_13_2","unstructured":"World Health Organization.International Classification of Diseases 10th Rev.Chapter XII. Diseases of the skin and subcutaneous tissue. Papulosquamous disorders L40 Available from URL:http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en(Accessed 29 April 2012.)"},{"key":"e_1_2_6_14_2","first-page":"205\u20136","article-title":"On the limitation of the psoriasis area severity index (PASI) (letter)","volume":"126","author":"Van de Kerhof PCM","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06502.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"e_1_2_6_17_2","unstructured":"World Health Organisation.Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva:World Health Organisation 2006."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1559-4564.2007.07392.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35354"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04556.x"},{"key":"e_1_2_6_21_2","unstructured":"BioPredictive.Biomarqueurs Non\u2010Invasifs des Maladies du Foie. Available from URL:http:\/\/www.biopredictive.com(Accessed 29 April 2012.)"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719577"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1381\/0960892055002347"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20323"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01718.x"},{"key":"e_1_2_6_26_2","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"Prashanth M","year":"2009","journal-title":"J. Assoc. Physicians India"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.055"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.027086"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00719.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00271-5"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2642"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006490200"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313478200"},{"key":"e_1_2_6_34_2","first-page":"297","article-title":"Insulin resistance in psoriasis","volume":"28","author":"Brenelli SL","year":"1995","journal-title":"Braz. J. Med. Biol. Res."},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08190.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02504.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non alcoholic fatty liver disease: population based study","volume":"76","author":"Amarapurkar D","year":"2007","journal-title":"Ann. Hepatol."},{"key":"e_1_2_6_38_2","first-page":"115","article-title":"Serum TNF\u2010 alpha levels correlate with disease severity and are reduced by effective therapy in plaque\u2010type psoriasis","volume":"11","author":"Mussi A","year":"1997","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01768.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10935"},{"key":"e_1_2_6_41_2","first-page":"120","article-title":"Interleukin\u20106 and soluble interleukin\u20102 receptor alpha\u2010markers of inflammation in patients with psoriatic arthritis?","volume":"27","author":"Alenius GM","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20283"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01709.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117495"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20280"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08823.x"},{"key":"e_1_2_6_47_2","first-page":"667","article-title":"Adiponectin as an anti\u2010inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy","volume":"163","author":"Shibata S","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"e_1_2_6_48_2","first-page":"1349","article-title":"Liver pathology in morbidly obese patients with and without diabetes","volume":"85","author":"Silverman JF","year":"1990","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03586.x"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-6"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-5926-4-10"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2012.00905.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2012.00905.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T03:00:58Z","timestamp":1698721258000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2012.00905.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1440-0960.2012.00905.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2012.00905.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,6]]},"assertion":[{"value":"2012-06-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}